Polyalanine Repeat Polymorphism in RUNX2 Is Associated with Site-Specific Fracture in Post-Menopausal Females

PLoS ONE

Volumn 8, Issue 9, 2013, Pages

  Morrison, Nigel A ^a   Stephens, Alexandre S ^a   Osato, Motomi ^b   Pasco, Julie A ^c   Fozzard, Nicolette ^a   Stein, Gary S ^d   Polly, Patsie ^e   Griffiths, Lyn R ^a   Nicholson, Geoff C ^f  

^a GRIFFITH UNIVERSITY   (Australia)

^b NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^c DEAKIN UNIVERSITY   (Australia)

^d UNIVERSITY OF VERMONT COLLEGE OF MEDICINE   (United States)

^e UNIVERSITY OF NEW SOUTH WALES   (Australia)

^f UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ALKALINE PHOSPHATASE BONE ISOENZYME; CARBOXY TERMINAL TELOPEPTIDE; POLYALANINE; POLYPEPTIDE; TRANSCRIPTION FACTOR RUNX2; UNCLASSIFIED DRUG;

ADULT; ANKLE FRACTURE; ARM FRACTURE; ARTICLE; BONE DENSITY; BONE TURNOVER; CELL NUCLEUS; CELLULAR DISTRIBUTION; CLAVICLE FRACTURE; CONTROLLED STUDY; FACE FRACTURE; FEMALE; FRACTURE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENETIC RISK; HETEROZYGOTE; HIP FRACTURE; HOMOZYGOTE; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MANDIBLE FRACTURE; PELVIS FRACTURE; POSTMENOPAUSE; RADIUS FRACTURE; RIB FRACTURE; RUNX2 GENE; SCAPULA; SCAPULA FRACTURE; SPINE FRACTURE; STERNUM; STERNUM FRACTURE; TRANSACTIVATION;

ALLELES; BASE SEQUENCE; BONE DENSITY; CORE BINDING FACTOR ALPHA 1 SUBUNIT; DNA PRIMERS; FEMALE; FRACTURES, BONE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MIDDLE AGED; PEPTIDES; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; POSTMENOPAUSE;

EID: 84884583287     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0072740     Document Type: Article

References (45)

1. McGuigan FE, Murray L, Gallagher A, Davey-Smith G, Neville CE, et al. (2002) Genetic and environmental determinants of peak bone mass in young men and women. J Bone Miner Res 17: 1273-1279.
2. Kanis JA, Melton III LJ, Christiansen J, Johnston CC, Khaltaev N, (1994) The diagnosis of osteoporosis. J Bone Miner Res 9: 1137-1141.
3. Chan MY, Nguyen ND, Center JR, Eisman JA, Nguyen TV, (2012) Absolute fracture-risk prediction by a combination of calcaneal quantitative ultrasound and bone mineral density. Calcif Tissue Int 90: 128-136.
4. Ducy P, Zhang R, Geoffroy V, Ridall AL, Karsenty G, (1997) Osf2/Cbfa1: a transcriptional activator of osteoblast differentiation. Cell 89: 747-754.
5. Komori T, Yagi H, Nomura S, Yamaguchi A, Sasaki K, et al. (1997) Targeted disruption of Cbfa1 results in a complete lack of bone formation owing to maturational arrest of osteoblasts. Cell 89: 755-764.
6. Otto F, Thornell AP, Crompton T, Denzel A, Gilmour KC, et al. (1997) Cbfa1, a candidate gene for cleidocranial dysplasia syndrome, is essential for osteoblast differentiation and bone development. Cell 89: 765-771.
7. Mundlos S, Otto F, Mundlos C, Mulliken JB, Aylsworth AS, et al. (1997) Mutations involving the transcription factor CBFA1 cause cleidocranial dysplasia. Cell 89: 773-779.
8. Long F, (2011) Building strong bones: molecular regulation of the osteoblast lineage. Nat Rev Mol Cell Biol 13: 27-38.
9. Kanatani N, Fujita T, Fukuyama R, Liu W, Yoshida CA, et al. (2006) Cbf beta regulates Runx2 function isoform-dependently in postnatal bone development. Dev Biol 296: 48-61.
10. Yoshida T, Kanegane H, Osato M, Yanagida M, Miyawaki T, et al. (2002) Functional analysis of RUNX2 mutations in Japanese patients with cleidocranial dysplasia demonstrates novel genotype-phenotype correlations. Am J Hum Genet 71: 724-738.
11. Online Mendelian Inheritance in Man, OMIM®. McKusick-Nathans Institute of Genetic Medicine, Johns Hopkins University (Baltimore, MD). Available: http://omim.org/#119600, CLEIDOCRANIAL DYSPLASIA; CCD. Accessed 2012.
12. Scheuer L (2000) Developmental Juvenile Osteology. Academic Press.
13. Xiao Z, Awad HA, Liu S, Mahlios J, Zhang S, et al. (2005) Selective Runx2-II deficiency leads to low-turnover osteopenia in adult mice. Dev Biol 283: 345-356.
14. Liu JC, Lengner CJ, Gaur T, Lou Y, Hussain S, et al. (2011) Runx2 protein expression utilizes the Runx2 P1 promoter to establish osteoprogenitor cell number for normal bone formation. J Biol Chem 286: 30057-30070.
15. Sanders KM, Pasco JA, Ugoni AM, Nicholson GC, Seeman E, et al. (1998) The exclusion of high trauma fractures may underestimate the prevalence of bone fragility fractures in the community: the Geelong Osteoporosis Study. J Bone Miner Res 13: 1337-1342.
16. Henry MJ, Pasco JA, Seeman E, Nicholson GC, Kotowicz MA, (2000) Prevalence of osteoporosis in Australian women: Geelong osteoporosis study. J Clin Densitom 3: 261-268.
17. Carter DR, Bouxsein ML, Marcus R, (1992) New approaches for interpreting projected bone densitometry data. J Bone Miner Res 7: 137-145.
18. Pasco JA, Henry MJ, Gaudry T, Nicholson GC, Kotowicz MA, (1999) Identification of incident fractures: the Geelong Osteoporosis Study. Aust N Z J Med 29: 203-206.
19. Sanders KM, Seeman E, Ugoni AM, Pasco JA, Martin TJ, et al. (1999) Age- and gender-specific rate of fractures in Australia: a population-based study. Osteoporos Int 10: 240-247.
20. Rosen HN, Moses AC, Garber J, Iloputaife ID, Ross DS, et al. (2000) Serum CTX: a new marker of bone resorption that shows treatment effect more often than other markers because of low coefficient of variability and large changes with bisphosphonate therapy. Calcif Tissue Int 66: 100-103.
21. Biver E, Chopin F, Coiffier G, Brentano TF, Bouvard B, et al. (2012) Bone turnover markers for osteoporotic status assessment? A systematic review of their diagnosis value at baseline in osteoporosis. Joint Bone Spine 79: 20-25.
22. Vaughan T, Pasco JA, Kotowicz MA, Nicholson GC, Morrison NA, (2002) Alleles of RUNX2/CBFA1 gene are associated with differences in bone mineral density and risk of fracture. J Bone Miner Res 17: 1527-1534.
23. Zhang YW, Yasui N, Ito K, Huang G, Fujii M, et al. (2000) A RUNX2/PEBP2alpha A/CBFA1 mutation displaying impaired transactivation and Smad interaction in cleidocranial dysplasia. Proc Natl Acad Sci USA 97: 10549-10554.
24. Morrison NA, Stephens AS, Osato M, Polly P, Tan TC, et al. (2012) Glutamine repeat variants in human RUNX2 associated with decreased femoral neck BMD, broadband ultrasound attenuation and target gene transactivation. Plos_ONE 7 (8) (): e42617.
25. Dyer BW, Ferrer FA, Klinedinst DK, Rodriguez R, (2000) A noncommercial dual luciferase enzyme assay system for reporter gene analysis. Anal Biochem 282: 158-161.
26. Green RE, Krause J, Briggs AW, Maricic T, Stenzel U, et al. (2010) A draft sequence of the Neandertal genome. Science 328: 710-722.
27. Crisci JL, Wong A, Good JM, Jensen JD, (2011) On characterizing adaptive events unique to modern humans. Genome Biol Evol 3: 791-798.
28. Meyer M, Kircher M, Gansauge MT, Li H, Racimo F, et al. (2012) A high-coverage genome sequence from an archaic Denisovan individual. Science 338: 222-226.
29. Franz-Odendaal TA, (2011) Induction and patterning of intramembranous bone. Front Biosci 16: 2734-2746.
30. Lou Y, Javed A, Hussain S, Colby J, Frederick D, et al. (2009) A Runx2 threshold for the cleidocranial dysplasia phenotype. Hum Mol Genet 18: 556-558.
31. Estrada K, Styrkarsdottir U, Evangelou E, Hsu YH, Duncan EL, et al. (2012) Genome-wide meta-analysis identifies 56 bone mineral density loci and reveals 14 loci associated with risk of fracture. Nat Genet 44: 491-501.
32. Doecke JD, Day CJ, Stephens AS, Carter SL, van Daal A, et al. (2006) Association of functionally different RUNX2 P2 promoter alleles with BMD. J Bone Miner Res 21: 265-273.
33. Bustamante M, Nogués X, Agueda L, Jurado S, Wesselius A, et al. (2007) Promoter 2-1025 T/C polymorphism in the RUNX2 gene is associated with femoral neck BMD in Spanish postmenopausal women. Calcif Tissue Int 81: 327-332.
34. Pineda B, Hermenegildo C, Laporta P, Tarín JJ, Cano A, et al. (2010) Common polymorphisms rather than rare genetic variants of the Runx2 gene are associated with femoral neck BMD in Spanish women. J Bone Miner Metab 28: 696-705.
35. Ermakov S, Malkin I, Keter M, Kobyliansky E, Livshits G, (2008) Family-based association study of polymorphisms in the RUNX2 locus with hand bone length and hand BMD. Ann Hum Genet 72: 510-518.
36. Lee HJ, Koh JM, Hwang JY, Choi KY, Lee SH, et al. (2009) Association of a RUNX2 promoter polymorphism with bone mineral density in postmenopausal Korean women. Calcif Tissue Int 84: 439-445.
37. Ermakov S, Malkin I, Kobyliansky E, Livshits G, (2006) Variation in femoral length is associated with polymorphisms in RUNX2 gene. Bone 38: 199-205.
38. Napierala D, Garcia-Rojas X, Sam K, Wakui K, Chen C, et al. (2005) Mutations and promoter SNPs in RUNX2, a transcriptional regulator of bone formation. Mol Genet Metab 86: 257-268.
39. Xiao ZS, Hjelmeland AB, Quarles LD, (2004) Selective deficiency of the "bone-related" Runx2-II unexpectedly preserves osteoblast-mediated skeletogenesis. J Biol Chem 79: 20307-20313.
40. Zhang S, Xiao Z, Luo J, He N, Mahlio J, et al. (2009) Dose dependent effect of RUNX2 on bone development. J Bone Miner Res 24: 1889-1904.
41. Cohen MM Jr, (2009) Perspectives on RUNX genes: an update. American Journal of Medical Genetics Part 149A: 2629-2646.
42. Fondon JW 3rd, Garner HR, (2004) Molecular origins of rapid and continuous morphological evolution. Proc Natl Acad Sci USA 101: 18058-18063.
43. Sears KE, Goswami A, Flynn JJ, Niswander LA, (2007) The correlated evolution of Runx2 tandem repeats, transcriptional activity, and facial length in carnivora. Evol Dev 9: 555-565.
44. Pointer MA, Kamilar JM, Warmuth V, Chester SGB, Delsuc F, et al. (2012) RUNX2 tandem repeats and the evolution of facial length in placental mammals. BMC Evol Biol 12: 103.
45. Green RM (2012) Analysis of RUNX2 gene's influence on bill morphology within shore birds. Thesis. University of Florida. Available: www.honors.ufl.edu/apps/Thesis.aspx/Download/51. Accessed online.